Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-222505
Filing Date
2013-05-15
Accepted
2013-05-15 16:33:02
Documents
9
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d511075d10q.htm 10-Q 277466
2 EX-31.1 d511075dex311.htm EX-31.1 8249
3 EX-32.1 d511075dex321.htm EX-32.1 3464
  Complete submission text file 0001193125-13-222505.txt   2960436

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT ttnp-20130331.xml EX-101.INS 302894
5 XBRL TAXONOMY EXTENSION SCHEMA ttnp-20130331.xsd EX-101.SCH 38862
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ttnp-20130331_cal.xml EX-101.CAL 37997
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ttnp-20130331_def.xml EX-101.DEF 92899
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE ttnp-20130331_lab.xml EX-101.LAB 282712
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ttnp-20130331_pre.xml EX-101.PRE 208506
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 4152444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

EIN.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-27436 | Film No.: 13847686
SIC: 2836 Biological Products, (No Diagnostic Substances)